Efficacy and Safety of Combined Surgeries including Intraocular Direct Cyclophotocoagulation with a 532 nm Laser to Treat Advanced Neovascular Glaucoma

Table 1

Patient baseline characteristics.

Parameter	Total (n = 25)
No. of eyes/patients	25/24
Gender (F/M, no. of patients)	13/11
Age (yrs)
Mean ± SD	58.3 ± 8.1
Range	42–70
Ischemic retinal disease, no. (%)
PDR	16 (64)
CRVO	6 (24)
OIS	2 (8)
BCVA (LogMAR)	3.46 ± 0.81
IOP (mmHg), mean ± SD	42.2 ± 8.5
Previous treatment, no. (%)
Complete PRP	3 (24)
Anti-VEGF	4 (16)
None	15 (60)
Topical antiglaucoma medication	2.72 ± 0.45
Lens status, no. (%)
Phakia	22 (88)
Pseudophakia	3 (2)
Aphakia	0 (0)
NVI grade
Grade 0	0 (0)
Grade 1	0 (0)
Grade 2	5 (20)
Grade 3	9 (36)
Grade 4	11 (44)
Anterior chamber angle
180° closed	6 (24)
270° closed	8 (32)
360° closed	11 (44)

Values are presented as number, mean ± SD, or number (%). BCVA: best-corrected visual acuity; CRVO: central retinal vein occlusion; OIS: ocular ischemic syndrome; PDR: proliferative diabetic retinopathy; SD: standard deviation.